Group 1 - The core viewpoint of the article highlights that Aidi Kang Holdings (09860.HK) has experienced a significant increase in stock price, rising over 5% in a single day and accumulating a total increase of 20% over the past three trading days [2] - As of the report, Aidi Kang Holdings' stock price reached 5.4 HKD, with a trading volume of 17.98 million HKD [2] - The recent performance indicates strong market interest and potential investor confidence in Aidi Kang Holdings [2]

Core Viewpoint - The stock of Aidi Kang Holdings (09860) has increased by over 5%, with a cumulative rise of 20% over the past three trading days, reflecting positive market sentiment towards AI in the healthcare sector [1] Group 1: Market Performance - Aidi Kang's stock price rose by 5.68% to HKD 5.4, with a trading volume of HKD 17.98 million [1] Group 2: Industry Developments - Recent favorable developments in the AI healthcare sector include a partnership between NVIDIA and Eli Lilly, committing USD 1 billion to establish a joint research lab in the San Francisco Bay Area over the next five years [1] - OpenAI announced the acquisition of healthcare tech startup Torch, indicating a growing interest in AI applications within the medical field [1] - Domestic AI healthcare applications are also accelerating, with Ant Group's AI healthcare product, Aifu, surpassing 15 million monthly active users, and major internet companies like ByteDance, Baidu, JD.com, and Tencent making significant investments in this area [1] Group 3: Company Collaborations - Aidi Kang signed a cooperation agreement with Huawei Cloud in December 2025, marking a new phase in collaborative innovation in smart healthcare [1] - The partnership aims to integrate AI technology into healthcare services, transitioning from traditional models to intelligent and ecological systems, representing a significant milestone in medical testing services [1]

艾迪康控股(09860)再涨超5%，近三个交易日累涨两成。截至发稿，涨5.68%，报5.4港元，成交额 1798.16万港元。 消息面上，近期AI医疗领域利好催化密集。英伟达与美国制药巨头礼来当地时间周一宣布，双方将在 未来五年内投入10亿美元，在旧金山湾区建设一座联合研究实验室，旨在加速人工智能(AI)在制药行业 中的应用。此外，OpenAI周一在社交媒体X平台上宣布，已收购医疗科技初创公司Torch。值得一提的 是，国内AI医疗应用亦呈现加速发展态势，蚂蚁旗下AI医疗产品阿福月活用户已突破1500万，字节、 百度、京东、腾讯等互联网大厂相继布局。 据悉，2025年12月，艾迪康与华为云正式签署合作协议，标志着双方在智慧医疗领域的协同创新步入全 新阶段。艾迪康与华为云此次携手合作，共同开启了以AI技术为引擎的智慧医疗新篇章。此次合作不 仅是技术能力与行业场景的深度融合，更是医学检验服务从传统模式向智能化、生态化演进的重要里程 碑。 ...

Group 1: Market Performance - The Hang Seng Index rose by 0.86%, gaining 224 points to close at 26,456 points, while the Hang Seng Tech Index increased by 2.08% [1] - The early trading volume in the Hong Kong stock market reached HKD 168.4 billion [1] Group 2: AI and Technology Sector - Leading AI model companies saw significant gains, with MINIMAX-WP (00100) up over 31% and Zhiyun (02513) rising by 30% due to a strategic partnership with Didi [1] - Other AI-related stocks also performed well, including Mifengshi (02556) which rose by 18%, and AI pharmaceutical companies like Yingshi Intelligent (03696) up 12% and Yidu Tech (02158) up over 8% [1] - Kuaishou-W (01024) increased by 5.62%, with expectations of significant revenue growth in FY2026 due to its AI initiatives [1] - Kingdee International (00268) rose by 10.71%, benefiting from accelerated AI model integration in industrial processes [1] Group 3: Lithium Industry - Tianqi Lithium (09696) and Ganfeng Lithium (01772) saw increases of over 5% and 6% respectively, driven by export tax adjustments that may stimulate demand [1] Group 4: New Listings and Stock Movements - The new stock Hao Wei Group (00501) debuted with a 15% increase, recognized as a leading Fabless semiconductor design company [2] - LFG Investment Holdings (03938) resumed trading and surged over 120% following a cash offer from Chen Shaoyang at a significant discount [2] Group 5: Regulatory Impact on Companies - Contemporary Amperex Technology Co., Ltd. (Ningde Times) fell by 2.94% due to new battery export tax policies and rising lithium carbonate prices [3] - Smoore International (06969) declined by 1.87% as the export tax rebate for electronic cigarettes is set to be canceled, potentially impacting profits [4]

Group 1 - The Hang Seng Index rose by 0.86%, gaining 224 points to close at 26,456 points, while the Hang Seng Tech Index increased by 2.08%. The morning trading volume reached HKD 168.4 billion [1] - Companies involved in AI large models saw significant gains, with MINIMAX-WP (00100) up over 31%, and Zhiyun (02513) rising by 30% after a strategic partnership with Didi to explore mobility agent scenarios [1] - The AI pharmaceutical sector also benefited from the surge in AI large models, with companies like Yingshi Intelligent (03696) up 12%, and Yidu Tech (02158) increasing by over 8% [1] Group 2 - Kuaishou-W (01024) increased by 5.62%, with its AI initiatives expected to significantly boost revenue for the fiscal year 2026 [2] - Kingdee International (00268) rose by 10.71%, driven by accelerated full-process empowerment through industrial large models and the implementation of multi-agent collaboration in its AI Starry Sky suite [3] - New stock Haowei Group (603501) (00501) debuted with a 15% increase, recognized as a leading Fabless semiconductor design company [4] Group 3 - LFG Investment Holdings (03938) resumed trading and surged over 120% following a cash offer from Chen Shaoyang at a discount of approximately 59.46% [5] - Contemporary Amperex Technology Co., Ltd. (300750) (03750) fell by 2.94% due to the introduction of a new battery export tax rebate policy, while lithium carbonate prices continued to rise [6] - Smoore International (06969) declined by 1.87% as the export tax rebate for electronic cigarettes is set to be canceled, potentially impacting the profits of related companies [7]

Group 1 - The core point of the news is the significant rise in the stock price of Aidi Kang Holdings, which increased by over 8% in early trading and is currently at 5 HKD with a trading volume of 5.22 million HKD [1] - OpenAI has launched ChatGPT Health, a dedicated space for health-related conversations that integrates with electronic medical records and various health applications, enhancing user interaction with personalized health information [1] - Anthropic announced the introduction of a new medical service compliant with HIPAA standards for its chatbot Claude, aimed at hospitals, healthcare providers, and consumers for handling protected health data [1] Group 2 - In the domestic AI healthcare application sector, Ant Group's "Afu" app has seen its monthly active users double to 30 million, with daily inquiries exceeding 10 million, attributed to its comprehensive service from health consultation to online appointment booking and insurance payment [2] - Aidi Kang Holdings has launched the "Aixiao Medical" intelligent assistant for doctors, offering a one-stop service that includes testing recommendations, intelligent consultations, report interpretations, and professional Q&A, while also developing a medical AI model "Wenyi" to enhance clinical decision support and multimodal data integration capabilities [2]

Group 1 - Eddiecon Holdings (09860) saw its stock price rise over 8% in early trading, currently up 6.38% at HKD 5, with a trading volume of HKD 5.2193 million [1] - OpenAI announced the launch of ChatGPT Health, a dedicated space for health-related conversations that integrates with electronic medical records and various health applications, providing responses based on user health information and personal context [1] - Anthropic introduced a new medical service compliant with HIPAA standards for its chatbot Claude, allowing hospitals, healthcare providers, and consumers to handle protected health data, while also enhancing its product with scientific databases and biology research capabilities [1] Group 2 - Domestic AI medical applications are leading, with Ant Group's "Afu" app doubling its monthly active users to 30 million and surpassing 10 million daily inquiries, attributed to its comprehensive service from health consultation to online appointment booking and insurance payment [2] - Eddiecon Holdings launched the "Aixiao Medical" intelligent assistant for doctors, offering a one-stop service that includes testing recommendations, intelligent consultations, report interpretations, and professional Q&A, while also developing a medical AI model "Wenyi" to enhance clinical decision support and multimodal data integration capabilities [2]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 艾迪康控股有限公司 呈交日期: 2026年1月5日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 09860 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,500,000,000 | USD | | 0.00002 | USD | | 50,000 | | 增加 / 減少 (-) | | | 0 | | | | USD | | | | 本月底結存 | | | 2,500,000,000 | USD | | 0.00002 | USD | | 50,000 | 本月底法定/註冊股本 ...

Core Insights - The "2025 Fifth China Health Industry Development and Rehabilitation Service Conference" was successfully held in Beijing, focusing on integrating resources across the health industry and exploring development paths under the theme "Intelligent Leadership for a Healthy Future" [1] Group 1: Industry Trends and Innovations - The conference featured high-level roundtable discussions on cutting-edge topics such as innovative drugs, brain-machine interfaces, AI in healthcare, and the transformation of traditional Chinese medicine [1] - A series of innovative case studies were released, showcasing advancements in areas like ESG, innovative drugs, biomedicine, AI healthcare, and social psychological services, highlighting the vitality and innovation within the health sector [1] Group 2: Company Highlights - **Jingtai Holdings** utilizes "AI + Robotics + Data" to accelerate drug development, having collaborated with major pharmaceutical companies and significantly expedited the market entry of Pfizer's COVID-19 oral drug Paxlovid by six months [3] - **Meinian Health** leverages AI technology for precise early screening and health management, continuously launching specialized products to meet diverse public health management needs [4] - **Dean Diagnostics** has developed an AI product matrix that enhances medical scene intelligence, achieving comprehensive coverage from hospitals to personal health management [5] - **Yingkang Life** integrates AI deeply into the entire medical service process, significantly improving medical capabilities and operational efficiency through its AI-driven platforms [6][7] - **New Mile Health Technology** is advancing a smart healthcare system that combines online and offline services, enhancing the digital landscape of managed healthcare [8] - **Airdoc** focuses on retinal AI imaging technology for chronic disease early screening and management, having provided diagnostic solutions to over 30 million people [9] - **Aidikang** employs AI-assisted imaging to enhance detection efficiency, achieving a performance rate of 6-7 times that of manual processes in key medical fields [10] - **Yidu Technology** has introduced the "Doctor Copilot" AI platform, which integrates seamlessly into clinical workflows, significantly enhancing the efficiency of healthcare services [11] - **Deepwise Medical** offers multi-modal AI solutions to various healthcare institutions, supporting high-quality development across the medical sector [12] - **Huadensen Bio** focuses on "precision diagnosis" through liquid biopsy technology, utilizing AI to improve the efficiency and accuracy of CTC detection [14]

致：香港交易及結算所有限公司 公司名稱: 艾迪康控股有限公司 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: 新提交 呈交日期: 2025年12月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 09860 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | 2,500,000,000 | | USD | | 0.00002 | USD | | 50,000 | | 增加 / 減少 (-) | | | 0 | | | | USD | | | | 本月底結存 | | | 2,500,000,000 | USD | | 0.00002 | USD | | 50,000 | 本月底法定/註冊股 ...